Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Sieber M, Tesch H, Pfistner B, Rueffer U, Lathan B, Brosteanu O, Paulus U, Koch T, Pfreundschuh M, Loeffler M, Engert A, Josting A, Wolf J, Hasenclever D, Franklin J, Duehmke E, Georgii A, Schalk KP, Kirchner H, Doelken G, Munker R, Koch P, Herrmann R, Greil R, Anselmo AP, Diehl V. Sieber M, et al. Among authors: koch p, koch t. J Clin Oncol. 2002 Jan 15;20(2):476-84. doi: 10.1200/JCO.2002.20.2.476. J Clin Oncol. 2002. PMID: 11786577 Clinical Trial.
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V; German Hodgkin's Lymphoma Study Group. Sieber M, et al. Among authors: koch p, koch t. J Clin Oncol. 2003 May 1;21(9):1734-9. doi: 10.1200/JCO.2003.06.028. J Clin Oncol. 2003. PMID: 12721249 Clinical Trial.
Spleen involvement in Hodgkin's lymphoma: assessment and risk profile.
Rueffer U, Sieber M, Stemberg M, Gossmann A, Josting A, Koch T, Grotenhermen F, Diehl V; German Hodgkin's Lymphoma Study Group (GHSG). Rueffer U, et al. Among authors: koch t. Ann Hematol. 2003 Jul;82(7):390-6. doi: 10.1007/s00277-003-0631-3. Epub 2003 May 23. Ann Hematol. 2003. PMID: 12764547
Venom-inspired somatostatin receptor 4 (SSTR4) agonists as new drug leads for peripheral pain conditions.
Bjørn-Yoshimoto WE, Ramiro IBL, Koch TL, Engholm E, Yeung HY, Sørensen KK, Goddard CM, Jensen KL, Smith NA, Martin LF, Smith BJ, Madsen KL, Jensen KJ, Patwardhan A, Safavi-Hemami H. Bjørn-Yoshimoto WE, et al. Among authors: koch tl. bioRxiv [Preprint]. 2024 Apr 30:2024.04.29.591104. doi: 10.1101/2024.04.29.591104. bioRxiv. 2024. PMID: 38746149 Free PMC article. Preprint.
Effects of positive end-expiratory pressure on pulmonary perfusion distribution and intrapulmonary shunt during one-lung ventilation in pigs A randomized crossover study.
Wittenstein J, Scharffenberg M, Fröhlich J, Rothmann C, Ran X, Zhang Y, Chai Y, Yang X, Müller S, Koch T, Huhle R, Gama de Abreu M. Wittenstein J, et al. Among authors: koch t. Anesthesiology. 2024 Apr 16. doi: 10.1097/ALN.0000000000005014. Online ahead of print. Anesthesiology. 2024. PMID: 38625679 Free article.
1,353 results